PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Journal of Health Informatics and Statistics10.21032/jhis.2016.41.3.3442016413344-350Influential Factors to Prolonged Tuberculosis Treatment Duration and Multidrug-resistant Tuberculosis IncidenceYoungsoon Choi, Yoonhee Tae, Jeeyoon Kimhttp://e-jhis.org/upload/pdf/jhis-41-3-344.pdf, http://e-jhis.org/journal/view.php?doi=10.21032/jhis.2016.41.3.344
BMC Public Health10.1186/s12889-018-5371-32018181Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, EthiopiaFanta Desissa, Tilaye Workineh, Takele Beyenehttp://link.springer.com/content/pdf/10.1186/s12889-018-5371-3.pdf, http://link.springer.com/article/10.1186/s12889-018-5371-3/fulltext.html, http://link.springer.com/content/pdf/10.1186/s12889-018-5371-3.pdf
Open Forum Infectious Diseases10.1093/ofid/ofv133.44320152suppl_1Multidrug-Resistant Tuberculosis Treatment as Prevention: Modeling the Population-Level Impact of Expanded Treatment for Multidrug-Resistant TuberculosisEmily Kendall, Andrew Azman, Frank Cobelens, David Dowdyhttps://academic.oup.com/ofid/article/doi/10.1093/ofid/ofv133.443/2634932
Indian Journal of Tuberculosis10.1016/j.ijtb.2016.05.009201663164Presumptive treatment of multidrug-resistant tuberculosis in household contactshttps://api.elsevier.com/content/article/PII:S0019570716301275?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0019570716301275?httpAccept=text/plain
10.21203/rs.2.15772/v32020Determinants Of Multidrug Resistant Tuberculosis Among Adultsundergoing Treatment For Tuberculosis In Tigray Region, Ethiopia: A Case Control Studyhttps://www.researchsquare.com/article/rs-6432/v3, https://www.researchsquare.com/article/rs-6432/v3.html
Indian Journal of Tuberculosis10.1016/j.ijtb.2016.11.0232016634277Drug-induced hypothyroidism during anti-tuberculosis treatment of multidrug-resistant tuberculosis: Notes from the fieldhttps://api.elsevier.com/content/article/PII:S0019570716303377?httpAccept=text/plain, https://api.elsevier.com/content/article/PII:S0019570716303377?httpAccept=text/xml
Nanotechnology Based Approaches for Tuberculosis Treatment10.1016/b978-0-12-819811-7.00014-x2020231-250Recent advancement and future perspective for the treatment of multidrug-resistant tuberculosisNoorsuzana Mohd Shariffhttps://api.elsevier.com/content/article/PII:B978012819811700014X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B978012819811700014X?httpAccept=text/plain
Tuberculosis10.1016/j.tube.2020.1019252020122101925Contributing risk factors towards the prevalence of multidrug-resistant tuberculosis in Malaysia: A systematic reviewMahindran Rajendran, Rafdzah Ahmad Zaki, Nasrin Aghamohammadihttps://api.elsevier.com/content/article/PII:S1472979220300925?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1472979220300925?httpAccept=text/plain
Egyptian Journal of Chest Diseases and Tuberculosis10.1016/j.ejcdt.2016.11.0022017663405-411Pattern of prevalence, risk factors and treatment outcomes among Egyptian patients with multidrug resistant tuberculosisEmad Ibrahim, Ayman Ibrahim Baess, Mahmoud Aly Al Messeryhttp://api.elsevier.com/content/article/PII:S0422763816302370?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S0422763816302370?httpAccept=text/plain
Respirology10.1111/resp.13206_15620172263-63MULTIDRUG-RESISTANT TUBERCULOSIS TREATMENT OUTCOME: TERTIARY CENTER EXPERIENCEhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fresp.13206_156, http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.13206_156/fullpdf